Evidence map›Paper›PMID 37426287›Full record

ArticleView (Beijing, China)2023

Theranostic applications of multifunctional carbon nanomaterials.

Shima Masoudi Asil, Erick Damian Guerrero, Georgina Bugarini, Joshua Cayme, Nydia De Avila, Jaime Garcia, Adrian Hernandez, Julia Mecado, Yazeneth Madero, Frida Moncayo and 9 more

Abstract read
In one paragraph

Article in View (Beijing, China), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shima Masoudi AsilDepartment of Environmental Science and Engineering, The University of Texas at El Paso, El Paso, Texas, USA.
Erick Damian GuerreroDepartment of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Georgina BugariniBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Joshua CaymeBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Nydia De AvilaBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Jaime GarciaBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Adrian HernandezBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Julia MecadoBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Yazeneth MaderoBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Frida MoncayoBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Rosario OlmosBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
David PerchesBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Jacob RomanBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Diana Salcido-PadillaBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Efrain SanchezBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Christopher TrejoBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Paulina TrevinoBUILDing SCHOLARS, Research Intensive Sequence (FYRIS) students, The University of Texas at El Paso, El Paso, Texas, USA.
Md NurunnabiDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, El Paso, Texas, USA.
Mahesh NarayanDepartment of Chemistry and Biochemistry, The University of Texas at El Paso, El Paso, Texas, USA.ORCID 0000-0002-2194-5228

Funding

Phase II of BUILDing SCHOLARSUL1GM118970 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$17.9M
Development and testing of Carbon Quantum Dot architectures to arrest neurotoxicant-insult- related outcomesR16GM145575 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI NARAYAN, MAHESH · 2022 to 2025
$769k
NIGMS NIH HHS R16 GM145575NIGMS NIH HHS UL1 GM118970
6 · The paper itself

Abstract

Nanobiotechnology is one of the leading research areas in biomedical science, developing rapidly worldwide. Among various types of nanoparticles, carbon nanomaterials (CNMs) have attracted a great deal of attention from the scientific community, especially with respect to their prospective application in the field of disease diagnosis and therapy. The unique features of these nanomaterials, including favorable size, high surface area, and electrical, structural, optical, and chemical properties, have provided an excellent opportunity for their utilization in theranostic systems. Carbon nanotubes, carbon quantum dots, graphene, and fullerene are the most employed CNMs in biomedical fields. They have been considered safe and efficient for non-invasive diagnostic techniques such as fluorescence imaging, magnetic resonance imaging, and biosensors. Various functionalized CNMs exhibit a great capacity to improve cell targeting of anti-cancer drugs. Due to their thermal properties, they have been extensively used in cancer photothermal and photodynamic therapy assisted by laser irradiation and CNMs. CNMs also can cross the blood-brain barrier and have the potential to treat various brain disorders, for instance, neurodegenerative diseases, by removing amyloid fibrils. This review has summarized and emphasized on biomedical application of CNMs and their recent advances in diagnosis and therapy.

Indexed as

carbon nanotubecarbon quantum dotsdiagnosisfullerenegraphenetherapy

Identifiers

PMID37426287
PMCPMC10328449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.